#neurological-disorders

#neurological-disorders

Microplastic pollution is rising and may be affecting human brain health, but the health impacts remain largely unclear.

Climate change impacts neurological conditions like stroke, epilepsy, MS, and mental health. Higher temperatures worsen symptoms, affecting brain diseases due to climatic variations.

Spasmodic dysphonia is a rare disorder affecting speech, characterized by involuntary spasms of the vocal cords.

Robert F. Kennedy Jr. has struggled with spasmodic dysphonia, a neurological condition affecting his voice, which impacts his public speaking.

Robert F. Kennedy Jr. has spasmodic dysphonia, affecting his voice quality, a condition he has managed for decades.

Restless Legs Syndrome (RLS) profoundly affects sleep and quality of life, yet many seek solutions in vain.

Parkinson's Disease symptoms can vary significantly among individuals and can change over time, even with ongoing treatment.

Understanding human neurons' energy demands may pave the way for treatments of neurological disorders.

Mice share significant genetic similarities with humans, aiding medical research, yet their behavioral responses under different conditions complicate their use as reliable models for human neurological disorders.

Human brain-on-a-chip technology is essential for advancing treatments for neurological disorders like Alzheimer's by enabling real-time analysis and addressing the blood-brain barrier.

Artificial intelligence technology enabled April Kerner to communicate using a program that replicates her voice, significantly impacting her connection with family.

New neurons formed in adult brains contribute to learning and memory, particularly in situations involving listening and social interactions.

New neurons in the adult brain are linked to learning and memory, especially in verbal communication.

Parkinson's disease symptoms vary greatly by individual and include tremors, rigidity, and movement difficulties that typically worsen over time.

Brett Favre's Parkinson's diagnosis underscores the disease's prevalence and the ongoing challenges it poses to many individuals.

Scientists engineered Toxoplasma gondii to act as a carrier for therapeutic proteins, potentially treating neurological disorders by bypassing the blood-brain barrier.

AAVs have potential for gene therapy but struggle to cross the blood-brain barrier, complicating treatments for brain disorders.